Management of Behcet's disease

Alibaz-Oner F., Sawalha A. H., Direskeneli H.

CURRENT OPINION IN RHEUMATOLOGY, cilt.30, sa.3, ss.238-242, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1097/bor.0000000000000497
  • Dergi Adı: CURRENT OPINION IN RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.238-242
  • Anahtar Kelimeler: Behcet's disease, interferon-alpha, interleukin-1 inhibitors, tumor necrosis factor-alpha inhibitors, tocilizumab, ANTI-TNF-ALPHA, DOUBLE-BLIND, INTERFERON ALPHA-2A, REMISSION INDUCTION, CLINICAL-OUTCOMES, CASE SERIES, ADALIMUMAB, THERAPY, MULTICENTER, EFFICACY
  • Marmara Üniversitesi Adresli: Evet

Özet

Purpose of review